Diasorin Inc. recalls
Diasorin Inc. is named on 2 recalls in Recall Relay's records since November 2023, from FDA; the most recent was November 7, 2024.
All 2, newest first.
-
Class IIofficial
Diasorin Inc. recalls DiaSorin LIAISON Q.S.E.T. Device PlusCustomer complaints were received alleging leaking devices and insufficient buffer volume. Diasorin's internal investigation determined that 0.14% of the LIAISON Q.S.E.T. Device Plus in the lots identified have loose clear caps, which may allow buffer to leak from the tube. A stool sample prepared with less than the correct amount of buffer may result an incorrectly high patient result.
-
Class IIofficial
Diasorin Inc. recalls DiaSorin LIAISON HSV-2 Type Specific IgGDiaSorin has identified that lots 136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C 136775of LIAISON HSV-2 Type Specific IgG assay may produce increased equivocal and/or false positive results.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Diasorin Inc. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts